Log in to save to my catalogue

TNK cells (NKG2D⁺ CD8⁺ or CD4⁺ T lymphocytes) in the control of human tumors

TNK cells (NKG2D⁺ CD8⁺ or CD4⁺ T lymphocytes) in the control of human tumors

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11030286

TNK cells (NKG2D⁺ CD8⁺ or CD4⁺ T lymphocytes) in the control of human tumors

About this item

Full title

TNK cells (NKG2D⁺ CD8⁺ or CD4⁺ T lymphocytes) in the control of human tumors

Publisher

Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag

Journal title

Cancer Immunology, Immunotherapy, 2009-05, Vol.58 (5), p.801-808

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag

More information

Scope and Contents

Contents

Innate and adaptive immune responses have many interactions that are regulated by the balance of signals initiated by a variety of activatory and inhibitory receptors. Among these, the NKG2D molecule was identified as expressed by T lymphocytes, including most CD8⁺ cells and a minority of CD4⁺ cells, designated TNK cells in this paper. Tumor cells...

Alternative Titles

Full title

TNK cells (NKG2D⁺ CD8⁺ or CD4⁺ T lymphocytes) in the control of human tumors

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11030286

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11030286

Other Identifiers

ISSN

0340-7004

E-ISSN

1432-0851

DOI

10.1007/s00262-008-0635-x

How to access this item